SecBot SecBot
PRESS-RELEASE ·Filed Aug 5, 2026

MDLN

Medline Inc.
MIXED
Impact 6/10
Horizonweeks Processed3mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

The strong EPS beat and raised organic sales guidance are positive, but the EBITDA guidance cut and $336M fire loss create significant uncertainty. Monitor the Q3 2026 call for updates on insurance recoveries, the pace of operational investments, and whether the Middle East conflict continues to pressure margins. The mixed signals suggest the stock may trade range-bound until the EBITDA trajectory becomes clearer.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$36.67
T+0 close · Aug 5, 2026 · via day close
Latest settled
−12.72%
T+60 · $32.00
Vs SPY
−12.67%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 5 $36.67entry
  2. T+1 · 3mo ago −5.88%α −5.72% · $34.51
  3. T+5 · 3mo ago −3.18%α −3.53% · $35.50
  4. T+20 · 3mo ago −1.00%α −0.39% · $36.30
  5. T+60 · 18d ago −12.72%α −12.67% · $32.00
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.32 by 56%, and revenue of $7.69B, beating $7.51B by 2.3%. Organic sales guidance was raised to 9.0%-10.0% from 8.5%-9.5%, but Adjusted EBITDA guidance was cut to $3.3-$3.4B from $3.5-$3.6B, reflecting inflationary pressure, operational investments, and a $336M fire loss at the Tracy distribution center. The mixed guidance and one-time fire loss temper the strong headline beat.

Key Financial Metrics

EPS
$0.50
est $0.32 · +56.3%
Revenue
$7.7B
est $7.5B · +2.3% · +11.6% YoY
Rating
beat
Guidance
Organic sales growth 9.0%-10.0%
Free Cash Flow
$920.0M
Gross Margin
28.8%

Key Facts

  • Q2 2026 adjusted EPS of $0.50 beat consensus of $0.32 by 56%.
  • Q2 2026 net sales of $7.7B increased 11.6% YoY, beating consensus of $7.51B.
  • Organic sales guidance raised to 9.0%-10.0% from 8.5%-9.5%.
  • Adjusted EBITDA guidance cut to $3.3-$3.4B from $3.5-$3.6B.
  • Net income fell 58.3% to $139M due to a $336M fire loss at the Tracy distribution center.
  • Q2 2026 GAAP diluted EPS was $0.07; adjusted diluted EPS was $0.50.
  • First six months 2026 free cash flow was $920M, up 37.1% YoY.
  • Net leverage stood at 2.9x trailing-twelve-month Adjusted EBITDA.

Financial Impact

EPS beat by $0.18 (56%) vs consensus; revenue beat by ~$180M (2.3%); EBITDA guidance cut by $200-300M at midpoint.

revenueepsebitdaguidance

Risk Factors

  • Adjusted EBITDA guidance cut by ~$300M at midpoint signals margin compression from inflation and investments.
  • $336M fire loss at Tracy distribution center creates operational disruption and insurance recovery uncertainty.
  • GAAP net income fell 58.3% YoY, highlighting the gap between adjusted and reported profitability.
  • Higher operating expenses and cost of goods sold from tariffs and Middle East conflict may persist.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3339217

Track record

30 reports on MDLN

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.17 −7.61% settles Nov 23
  2. Nov 16, 2026today S-1 Neutral 4/10 Entry price pending
  3. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  4. Nov 13, 20263d ago 144 Neutral 2/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  5. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $39.17 −3.78% ▼ −3.78% −2.09% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  7. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.17 −2.92% ▲ +4.49% +5.40% vs SPY
  8. Nov 2, 202613d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.17 −14.90% ▼ −20.01% −20.59% vs SPY
  9. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.17 +21.95% ▲ +23.41% +26.12% vs SPY
  10. Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.17 −12.30% ▲ +8.26% +8.96% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026